OptiBiotix Health (LON:OPTI) Posts Earnings Results

OptiBiotix Health (LON:OPTI) issued its quarterly earnings results on Thursday. The company reported GBX (1.52) earnings per share for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.

OptiBiotix Health Stock Performance

LON OPTI traded down GBX 0.62 during trading hours on Thursday, hitting GBX 5.98. 1,015,389 shares of the company’s stock were exchanged, compared to its average volume of 355,082. The business’s 50 day moving average is GBX 5.80 and its 200-day moving average is GBX 5.74. OptiBiotix Health has a 12-month low of GBX 4.50 and a 12-month high of GBX 12.25. The firm has a market capitalization of £6.18 million, a P/E ratio of -1.56 and a beta of 1.82.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.